Sanofi "enjoys a very, very broad portfolio and it's also a leader in vaccine manufacturing, not necessarily Covid but just vaccine manufacturers, and I think the whole move towards vaccination due to Covid awareness has really grown quite a lot and Sanofi is going to benefit from that the next couple of years," Schlossberg told CNBC'sAs investors wait for those tail winds to give the stock a lift, Schlossberg said its current fundamentals and pipeline also make Sanofi a solid...
"It's also just sort of a very, very steady stock. It's got a 3.8% dividend, which makes it very attractive in this environment, and it does have one very good drug which is called Dupixent which basically allows for treatment of eczema in young children but it'sU.S. Food and Drug Administration in May approved Sanofi's DupixentSanofi shares have underperformed the broader health-care sector this year, though.
"It's been this tale of two health cares where what had been a broader move earlier in the year has become much more dispersed where you have a sector of haves and have-nots," Wald said during the same "Trading Nation" segment. "We would be advising going underweight large-cap pharma against an overweight position in small-cap biotech."
The Russell 2000 biotech index has risen 57% so far this year. The S&P 500 pharmaceutical subsector, which includes
You are not to Condem anyone you spew hate Americans are well aware all been exposed. Americans rejected this hate..
Pushing drugs on everyone. It’s legal for a public traded company to do so. Deaths are not calculated.
Remember this is all bollocks! Covid is measured using a flawed testing method that produces false positive results, deaths that have been reclassified regardless of the actual cause, and a 99.9% recovery rate! Plandemic Agenda21 ID2020 Lockstep GreatReset Coronavirus
this is terrible news